JUN 20, 2018 9:00 AM PDT

Identifying Driver Alterations and Therapeutic Options in Cancer

Speaker
  • Head of Knowledge Systems, Marie-Josée & Henry R. Kravis Center for Molecular Oncology
    Biography
      Nikolaus Schultz leads the development of the cBioPortal for Cancer Genomics, a popular resource for the visualization and analysis of large-scale cancer genomics data sets. His research focuses on identifying the genomic alterations that underlie different types of cancer. He is involved in several projects of The Cancer Genome Atlas (TCGA) and is an investigator in the Stand Up To Cancer (SU2C) Prostate Cancer Dream Team.

      Dr. Schultz is an Associate Attending Computational Oncologist in the Department of Epidemiology and Biostatistics and an affiliate member of the Human Oncology and Pathogenesis Program. He is the Head of Knowledge Systems in the Marie-Josée and Henry R. Kravis Center for Molecular Oncology.

    Abstract

    With prospective clinical sequencing of tumors emerging as a mainstay in cancer care, there is an urgent need for clinical support tools that aid clinicians in their decision making. To this end, we are developing tools for the visualization and interpretation of genomic variants in the context of clinical annotation. 

    To this end, we have developed OncoKB, a precision oncology knowledge base that annotates the effects and treatment implications of somatic mutations in cancer. OncoKB annotations are available for research use via oncokb.org, and the database is used to annotate the sequencing reports of of tumor samples from patients at Memorial Sloan Kettering Cancer Center. 

    We are also co-developers of the cBioPortal for Cancer Genomics. The cBioPortal is an open source software tool that provides intuitive visualization and analysis of cancer genomics data, allowing cross-cohort analyses but also the viewing and interpretation of individual tumor samples. The public site at cbioportal.org provides access to published sequencing data from more than 25,000 tumor samples, and private instances of cBioPortal are installed at multiple academic research centers, in hospitals, and pharmaceutical companies. Annotations from OncoKB as well as other sources, such as COSMIC, CIViC, and cancerhotspots.org, are integrated into cBioPortal to facilitate the interpretation of variants in cancer cohorts and individual patient samples.

    This presentation will summarize the challenges of precision oncology and cancer genomics research and will present how OncoKB and the cBioPortal for Cancer Genomics can be used to overcome some of these challenges.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    OCT 29, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 18, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    Loading Comments...
    Show Resources